12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
The article reports on the after-market movements of 12 health care stocks on Thursday. Notable gainers include OneMedNet, 23andMe Holding, and Biora Therapeutics, while significant losers include Genelux and Evoke Pharma.

May 23, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Evoke Pharma stock decreased by 10.64% to $0.42 in the after-market session. Market cap: $3.6 million.
The price decrease suggests negative investor sentiment, likely leading to short-term downward pressure.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Genelux shares fell 26.5% to $3.38 in the after-market session. Market cap: $91.2 million.
The significant price drop indicates negative investor sentiment, likely leading to short-term downward pressure.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Purple Biotech stock decreased by 4.89% to $0.76 following the release of their Q1 earnings report two days ago. Market cap: $19.8 million.
The price decrease following the Q1 earnings report suggests negative investor sentiment, likely leading to short-term downward pressure.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Biora Therapeutics stock increased by 10.0% to $0.55 in the after-market session. Market cap: $19.7 million.
The price increase suggests positive investor sentiment, likely leading to short-term upward momentum.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
23andMe Holding shares rose by 11.85% to $0.57 following the release of their Q4 earnings report. Market cap: $275.2 million.
The positive reaction to the Q4 earnings report indicates strong investor confidence, likely driving short-term gains.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
OneMedNet stock increased by 15.6% to $1.7 in the after-market session, with a market cap of $40.5 million.
The significant price increase suggests positive investor sentiment, likely leading to short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80